AWS Cuts Pharma R&D Cycles, NHS Tests Cancer AI, Insilico Hits Phase III

Sponsored by

AI HUSTLE | July 14, 2026

Every sales operator knows the pain of losing a high-value prospect to a competitor. But in modern B2B sales, "closed-lost" doesn't mean the deal is dead—it just means the clock has started ticking. When a buyer signs with a competitor, they enter a high-risk onboarding window. If promises aren't met, buyer’s remorse sets in. This week, we are showing you how to build an automated engine that monitors competitor failures and automatically swoops in with a hyper-personalized, high-converting "win-back" campaign at the exact moment your prospect is regretting their decision.

Stop Managing Tools. Start Running Your Business.

Most e-commerce sellers are running their store across 6 to 8 separate tools — and spending more time managing software than growing their business. StoreClaw replaces your entire stack with one autonomous AI engine that monitors competitors, optimizes listings, automates marketing, and tracks real profit across Shopify, Amazon, and beyond.

It doesn't wait for you to ask. It runs 24/7 in the background, so you wake up to a full dashboard instead of a list of things you forgot to check.

Connect your store, and StoreClaw gets to work — no prompts, no complex setup, no six-app stack.

Free to start. No credit card required.

Try it for free today

The Hustle: The "Buyer's Remorse" Resuscitation Engine

The Goal: Automatically win back deals that chose a competitor by targeting them with precision outreach the moment they experience post-purchase regret.

The Tools:

* CRM: Salesforce or HubSpot (To track deal status and lost competitors)

* Automation Platform: Make.com or Zapier

* Web Scraper: Apify or ScrapingBee (To monitor competitor review sites)

* AI Model: Claude 3.5 Sonnet or OpenAI GPT-4o (To analyze issues and draft emails)

Step 1: Tracking the Lost Competitor (The Input)

When a sales rep marks a deal as "Closed-Lost" in your CRM, enforce a required field: "Lost to Which Competitor?" as well as the loss reason. The moment the status updates to "Closed-Lost to Competitor," your CRM pushes this metadata (Prospect Name, Email, Competitor Name, and Date) directly to Make.com via a webhook.

Step 2: Setting the Onboarding Timer (The Trigger)

Once Make.com receives the payload, it triggers a delay router. Instead of reaching out immediately, the automation schedules a task for exactly 90 days in the future. Why 90 days? This is the standard business window where the "honeymoon phase" with a new vendor ends, implementation roadblocks appear, and buyer's remorse peaks.

Step 3: Scraping Competitor Pain Points (The AI/Logic)

On day 90, the automation triggers a web scraper to fetch the latest 5-10 negative reviews and software release notes for that specific competitor from platforms like G2, Capterra, or Trustpilot.

Make.com passes these reviews to an LLM with a prompt like: "Review these recent complaints about [Competitor]. Identify the top 2 software glitches, support delays, or onboarding bottlenecks users have complained about over the last 30 days."

Step 4: The Hyper-Specific Olive Branch (The Output)

Using the identified pain points, the AI drafts a highly relevant, non-confrontational email template and saves it as a draft in your sales rep’s inbox.

The email reads:

"Hi John, usually by month three with [Competitor], teams start running into issues with [Specific Issue 1, e.g., slow API sync times] or [Specific Issue 2]. If your team is experiencing that bottleneck right now, we actually just built a migration tool that can get you onboarded with us in under 48 hours. Let me know if you want to take a look." 

The rep reviews the drafted email, hits send, and intercepts a frustrated buyer at their most vulnerable moment.

Why This Hustle Works:

* Impeccable Timing: You are not cold-emailing; you are entering a conversation they are already having in their own head about their vendor's shortcomings.

* Low-Friction Transition: By explicitly mentioning a "migration tool" or a quick-onboarding solution, you eliminate the prospect's biggest fear: the pain of switching providers again.

[Webinar] 8 levels of context maturity in AI-native development

AI is in your development workflow. While the token spend shows it, the throughput doesn't. The human is very much still in the loop, and that's a context problem. Join live (FREE) on Jul 23 to see why teams get stuck and how leading teams use a context engine to fix it.

Register For Webinar

🚀 The AI Pulse: 3 Signals to Watch This Week

AWS GraphRAG Slashes Drug R&D Cycles by 87%

Amazon Web Services has deployed a powerful GraphRAG (Graph Retrieval-Augmented Generation) system that integrates disparate, unstructured databases—ranging from public medical journals to internal lab notes—into a unified knowledge graph. Operating on Amazon Neptune Analytics and powered by Claude 4.5 Sonnet via Amazon Bedrock, the setup allows scientists to run natural language queries that yield highly verified, traceable data connections. The system has collapsed the initial data-gathering phase of drug development from six months down to just three weeks, while ensuring compliance by providing clear audit trails for every AI-generated conclusion.

The Hustle Take: The business value here goes far beyond pharmaceuticals. "Data decay" and siloed legacy files cost enterprises millions when key employees resign and take context with them. By implementing a GraphRAG framework, operators can map their own internal operational notes, customer histories, and product databases into an interactive brain. If your company suffers from fragmented knowledge bases, building a GraphRAG system is now the gold standard for preserving intellectual property and speeding up internal decision-making.

NHS Prepares Low-Cost AI Blood Test to Triage Cancer Risk

Several NHS hospitals are gearing up to deploy an AI-driven blood test designed to help assess patients referred for suspected womb cancer. Developed by PinPoint Data Science, the test uses machine learning algorithms to analyze roughly 30 blood markers, grading patients as low, elevated, or high risk. In trials of over 16,000 patients, the £30 test successfully flagged 99.1% of cancers. Crucially, the tool is expected to rule out low-risk patients early, sparing up to 18,000 women per year in England from undergoing invasive transvaginal ultrasound scans while drastically reducing administrative strain on healthcare systems.

The Hustle Take: This is a prime example of "AI triage" in action. High-liability industries (like healthcare, insurance, and legal services) often struggle with bottlenecks because every intake requires senior expertise or invasive procedures. If you can build or deploy simple classification algorithms that screen out low-risk or standard cases at the front of your pipeline, you can drastically lower your operating costs and free up your human experts to focus purely on high-complexity, high-margin tasks.

Insilico Medicine Advances AI-Designed Drug to Phase III Trials

Insilico Medicine has entered Phase III human trials for rentosertib, a drug designed to treat idiopathic pulmonary fibrosis (IPF)—a severe, degenerative lung disease. Insilico’s proprietary software platform, Pharma.AI, bypassed traditional, multi-year laboratory screening. Its biology engine (PandaOmics) identified a novel cellular target, and its generative chemistry engine (Chemistry42) algorithmically designed 79 physical molecules to target the disease. The engineering team selected the 55th iteration to advance to clinical trials, bringing the timeline from project initiation to preclinical candidate validation down to an unprecedented 18 months.

The Hustle Take: We are officially moving out of the "AI hype" phase and into the "tangible physical outcomes" phase. Insilico did not just search a database; they used generative AI to build a physical compound that did not previously exist. If your business is involved in manufacturing, materials science, consumer packaged goods, or chemical formulation, relying on manual trial-and-error R&D is a legacy bottleneck. Investing in generative design tools is no longer a luxury—it is the only way to keep your product development cycles competitive.

Your competitor's growth lead already saw the spend spike.

While your team is still in standup, the other growth lead already got the alert. Viktor is an AI employee that lives in Slack. It watches your Meta and TikTok spend overnight, flags the underperformer by 7am, and drafts the new brief before your first meeting.

Get Started for Free